The Relative Strength (RS) Rating for Elanco Animal Health moved up into a new percentile Monday, as it got a lift from 66 to 75.
When To Sell Stocks To Lock In Profits And Minimize Losses
This unique rating identifies market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating of at least 80 as they begin their biggest climbs. See if Elanco Animal Health can continue to rebound and clear that threshold.
While Elanco Animal Health is not near an ideal entry right now, see if it manages to form and break out from a proper base.
Elanco Animal Health posted 9% EPS growth in the latest quarterly report, while sales growth came in at -1%.
Elanco Animal Health earns the No. 1 rank among its peers in the Medical-Supplies industry group. Henry Schein and Avanos Medical are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
